#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>By report
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Background Information: Characteristics: High intraocular pressure, globe enlargement and edema, corneal opacification, thinning of anterior sclera, iris atrophy, anomalous deep anterior chamber, photophobia, blepharospasm, and excessive tearing. Incidence: 1:5,000-20,000 individuals in Western countries; varies in other ethnicities. Inheritance: Autosomal recessive. Cause: Two Cytochrome P4501B1 (CYP1B1) gene mutations. Clinical Sensitivity: 20-100% in familial cases, 10-15% in isolated cases. Methodology: Bidirectional sequencing of the entire CYP1B1 coding region, intron-exon boundaries and 5 prime untranslated region. Analytical Sensitivity and Specificity: 99% Limitations: Large gene deletions/duplications and deep intronic mutations will not be detected.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.
See Compliance Statement C: www.aruplab.com/CS
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
81404
|
*ExistCPT>
|